How Safe Are Science Careers For Scientists?

Although much has been written about the difficulties that a new Ph.D. will have in getting into a first job after doing a postdoc, this article is about a different and vastly underdiscussed problem. That problem deals with hazards to the career of a scientist after he or she has been in a career for some time. These hazards often force capable scientists out of science. A scientist who is either in academia or in a research institute that permits investigator-originated research must perpetua

Written byArthur Sowers
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Although much has been written about the difficulties that a new Ph.D. will have in getting into a first job after doing a postdoc, this article is about a different and vastly underdiscussed problem. That problem deals with hazards to the career of a scientist after he or she has been in a career for some time. These hazards often force capable scientists out of science.

A scientist who is either in academia or in a research institute that permits investigator-originated research must perpetually deal with the probability that he or she will have to write at least five to 10 proposals before one of them will get funded (H.G. Mandel, Science, 269:13-4, 1995). To deal with this situation, scientists have had to expend greater amounts of their time on fund-raising and less on science. If any existing funding is interrupted, it usually leads to termination for those in jobs ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies